It's diagnostics, stupid.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 20371338.
- Also identified by DOI 10.1016/j.cell.2010.03.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To stem the spiraling cost of cancer treatment, a concerted effort is urgently needed to develop molecular diagnostics to better identify the patients that respond to expensive targeted therapies. Opportunities and obstacles in the development of such drug response biomarkers are discussed here.
Medical subject headings
- Biomarkers, Pharmacological
- Neoplasms